Amyloid β-Protein (10-20) is a fragment of Amyloid-β peptide, maybe used in the research of neurological disease.
Amyloid β-Protein 10-20 is a synthetic peptide fragment corresponding to residues 10 through 20 of the human amyloid beta (Aβ) sequence. As a defined segment of the Aβ peptide, it is distinguished by its involvement in the aggregation processes linked to amyloid plaque formation, a hallmark of neurodegenerative pathologies such as Alzheimer's disease. The 10-20 region of Aβ is notable for its contribution to peptide self-assembly, β-sheet formation, and interaction with a variety of molecular partners. Researchers leverage this fragment to dissect the structural and functional properties of amyloidogenic sequences, making it a valuable tool for advancing fundamental understanding of protein misfolding, aggregation kinetics, and molecular recognition events in neurobiology.
Aggregation studies: The 10-20 fragment of amyloid beta is frequently employed in in vitro aggregation assays to elucidate the sequence determinants of amyloid fibril formation. By isolating this specific region, investigators can examine its intrinsic propensity for β-sheet formation and its role in nucleating or modulating aggregate growth. These studies provide mechanistic insights into the early stages of amyloidogenesis, facilitating the identification of sequence motifs and intermolecular interactions that drive pathological aggregation.
Structure-activity relationship analysis: Researchers utilize the peptide to probe the relationship between primary sequence, secondary structure, and biological activity within the amyloid beta family. The defined sequence allows for systematic modifications, such as site-directed mutagenesis or incorporation of non-natural amino acids, enabling the mapping of key residues involved in molecular recognition, aggregation kinetics, and toxicity. Such analyses are critical for understanding how specific amino acid substitutions influence the conformational landscape and functional properties of amyloidogenic peptides.
Interaction mapping: The 10-20 segment serves as a model system for investigating interactions between amyloid beta and various molecular partners, including small molecules, antibodies, and chaperone proteins. By focusing on this region, researchers can delineate binding sites, characterize affinity and specificity, and evaluate the effects of potential aggregation inhibitors. These studies support the rational design of molecular probes and modulators that target amyloidogenic sequences with high precision.
Analytical method development: Synthetic peptides corresponding to amyloid beta regions, such as the 10-20 fragment, are widely used as standards and reference materials in analytical techniques. Applications include calibration and validation of mass spectrometry methods, high-performance liquid chromatography (HPLC) assays, and immunoassays designed to detect, quantify, or characterize amyloid beta species. The availability of well-defined peptide standards enhances the reliability and reproducibility of analytical workflows in neurodegenerative disease research.
Biophysical characterization: The defined sequence and physicochemical properties of the 10-20 fragment make it an excellent candidate for detailed biophysical studies. Techniques such as circular dichroism spectroscopy, nuclear magnetic resonance (NMR), and atomic force microscopy are employed to monitor conformational transitions, oligomerization states, and surface interactions. These investigations contribute to a deeper understanding of the structural dynamics and assembly mechanisms underlying amyloid formation, informing the development of novel diagnostic and research tools.
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More